share_log

Stifel Initiates Coverage On Mineralys Therapeutics With Buy Rating, Announces Price Target of $45

Stifel Initiates Coverage On Mineralys Therapeutics With Buy Rating, Announces Price Target of $45

Stifel以买入评级开始对Mineralys Therapeutics进行报道,宣布目标股价为45美元
Benzinga ·  2023/03/07 05:21

Stifel analyst Annabel Samimy initiates coverage on Mineralys Therapeutics (NASDAQ:MLYS) with a Buy rating and announces Price Target of $45.

Stifel分析师Annabel Samimy以买入评级启动对Mineralys治疗公司(纳斯达克:MLYS)的报道,并宣布目标价为45美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发